Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offer...
Akums Drugs and Pharmaceutical reported revenue of 43.59 billion INR for fiscal year 2026, up 7.1% from fiscal year 2025, and net income of 2.55 billion INR. Its largest business segment, CDMO, brought in 78% of segment revenue in fiscal year 2025. Its market capitalization was 115.05 billion INR as of October 12, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 12, 2026.
No profile data available.